France vs Switzerland: Laboratories providing drug susceptibility testing (DST)
France
4.7
in 2014
Switzerland
5.5
in 2014
France rank
25th
Switzerland rank
22nd
Laboratories providing drug susceptibility testing (DST) over time
- France
- Switzerland
How they compare
Switzerland currently reports 5.5 against 4.7 in France, a difference of 0.8.
That makes Switzerland's figure about 1.2 times France's.
Across all 6 years both countries report, Switzerland has been ahead every year.
France ranks 25th and Switzerland ranks 22nd of 157 countries.
Switzerland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | France | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9 | 18.9 | 9.9 | Switzerland |
| 2010s | 5.52 | 6.12 | 0.6 | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher laboratories providing drug susceptibility testing (dst), France or Switzerland?
- Switzerland, at 5.5 against 4.7 in France as of 2014.
- What is the difference in laboratories providing drug susceptibility testing (dst) between France and Switzerland?
- 0.8, with Switzerland ahead.
- How many years of comparable data are there for France and Switzerland?
- 6 years are reported by both, from 2005 to 2014.
- How do France and Switzerland rank globally for laboratories providing drug susceptibility testing (dst)?
- France ranks 25th and Switzerland ranks 22nd of 157 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Laboratories providing drug susceptibility testing (DST) (per 5 million population). Statizoid refreshes it automatically from the source and publishes the full history for both places.